Related Experiment Video
Updated: Apr 27, 2026
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Gastrointestinal stromal tumor: analysis of outcome and correlation with c-kit status in Indian population
S Cyriac1, R Rajendranath, T G Sagar
1Medical and Pediatric Oncologist, Caritas Cancer Institute, Kottayam, Kerala, India.
Aims:
The aim of the present study is to analyse the outcome and genotypic pattern of metastatic GIST patients which is largely unknown in India.
Materials And Methods:
The present study was a retrospective analysis of 24 patients of metastatic GIST. The case records were analysed for clinical profile, treatment response and prognostic factors. The archival samples were retrieved for c-kit mutation analysis in all but 5 patients for mutation analysis.
Results:
The median age of the study population was 56 years. At a median follow up of 29 months, the PFS was 45% at 2 years. Activating c-kit mutations were detected in 10 cases (52.6%). 80% of the mutations were located in Exon 11.
Conclusions:
The outcome of metastatic GIST patients has definitely improved from a virtually incurable state to a disease where median OS has reached 60 months. The genotype of Indian patients with GIST may be different from the western population which needs to be confirmed in a larger study.
